MM

Maruthi Manikanta Naralasetti

Active Director Director DIN 11760462
DIN 11760462 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Maruthi Manikanta Naralasetti

Data last updated:

Maruthi Manikanta Naralasetti is a Director at Clustyn Biosciences Private Limited (since 2026).

DIN 11760462
Primary Designation Director
First Appointment 08 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clustyn Biosciences Private Limited U47721AP2026PTC126264
Director08 Jun 20262026Active

Board colleagues of Maruthi Manikanta Naralasetti

Directorship timeline

Open interactive timeline →
Clustyn Biosciences Private Limited
Premium access

Shareholding and investment profile for Maruthi Manikanta Naralasetti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maruthi Manikanta Naralasetti

Maruthi Manikanta Naralasetti currently holds 1 directorship: Clustyn Biosciences Private Limited (Director, since 08 Jun 2026).

Maruthi Manikanta Naralasetti was first appointed on 08 Jun 2026 as Director at Clustyn Biosciences Private Limited.

The current boards of Maruthi Manikanta Naralasetti's companies include Satya Sree Seelamsetty (Clustyn Biosciences Private Limited), Satyanarayana Murthy Seelamsetty (Clustyn Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available